USDA licenses long-acting injectable for canine allergic dermatitisNovember 12, 2026 With a 75-day dosing interval, the monoclonal antibody (mAb) treatment helps reduce the number of clinic visits required for managing allergic dermatitis and lower the risk of missed doses.
Education Center - SponsoredIntegrating Therapeutic Nutrition for Chronic Allergiesby • Hill's Pet NutritionIntended for veterinary audiences